0.00Open0.00Pre Close0 Volume0 Open Interest21.00Strike Price0.00Turnover130.42%IV-21.46%PremiumDec 20, 2024Expiry Date3.71Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8667Delta0.0771Gamma4.46Leverage Ratio-0.0500Theta-0.0024Rho-3.87Eff Leverage0.0046Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet